Alefacept Monoclonal Antibody
Alefaceptis a research-grade recombinant antibody targeting CD2. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Erythrocyte receptor, SRBC, T-cell surface antigen CD2, Rosette receptor, CD2, LFA-3 receptor, T-cell surface antigen T11/Leu-5, LFA-2
UniProt
P06729
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, In vivo
Host or Source
Mammal
Preservative
0.01M PBS, pH 7.4.
Isotype
Fusion - [CD58 (LFA3, lymphocyte function associated antigen 3) ]2 - IGHG1 Fc (Fragment constant)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Pseudomonas aeruginosa serotype 6C (1200/472), 0.2mg/mL
17,21-Dihydroxypregna-1,4,9(11)-triene-3,20-dione
![(E)-3-(2-Fluorophenyl)-N-((S)-1-(3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]acrylamide](https://cdn.genprice.uk/products/572/4721503763738/imageurl/trc-f595708-5mg.webp)
(E)-3-(2-Fluorophenyl)-N-((S)-1-(3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-ethyl]acrylamide
